Summary:
We describe a patient with bcr/abl-positive acute mixed lineage leukemia who successfully underwent transplantation in primary induction failure, using unmanipulated bone marrow from a human leukocyte antigen (HLA)-haploidentical cousin. The tumor burden was successfully reduced by the administration of imatinib mesylate (STI571) before transplantation. As graft-versus-host disease (GVHD) prophylaxis, a combination of tacrolimus and a short course of methotrexate, methylprednisolone, and mycophenolate mofetil was used. Hematopoietic reconstitution was rapid, and acute GVHD was limited to the skin (grade I). The patient is still in complete remission past day +400. This successful case suggests that HLA-haploidentical transplantation using unmanipulated marrow from a distantly related relative can be considered for patients in urgent situations who do not have HLA-identical donors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864–3872.
Aversa F, Tabilio F, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186–1193.
Marmont A, Horowitz M, Gale R et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130.
Ogawa H, Soma T, Hosen N et al. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Transplantation 2002; 74: 236–243.
Ikegame K, Tanji Y, Kitai N et al. Successful treatment of refractory T cell acute lymphoblastic leukemia by the unmanupulated stem cell transplantation from an HLA 3 loci mismatched (haploidentical) sibling. Bone Marrow Transplant (in press).
Ogawa H, Tsuboi A, Oji Y et al. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay. Bone Marrow Transplant 1998; 21: 525–527.
Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia. Blood 1992; 79: 3067–3070.
Singhal S, Powles R, Henslee-Downey PJ et al. Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplant 2002; 29: 291–295.
Ottmann OG, Druker BJ, Sawyers CL et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965–1971.
Guinan EC, Boussiotis VA, Neuberg D et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340: 1704–1714.
Burlingham W, Railer A, Heisey D et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplantation sibling donors. N Engl J Med 1998; 339: 1657–1664.
Oh H, Zhang M-J, Akiyama H et al. Comparison of graft-versus-host disease (GVHD) and survival in different ethnic populations: collaborative study by the Japan Adult Leukemia Study Group (JALSG) and the International Bone Marrow Transplant Registry (IBMTR). Blood 2002; 100: 418 (Abstract 1621).
Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. Blood 1989; 74: 2252–2256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikegame, K., Mukouchi, C., Kunitomi, A. et al. Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin. Bone Marrow Transplant 31, 1165–1168 (2003). https://doi.org/10.1038/sj.bmt.1704064
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704064
Keywords
This article is cited by
-
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study
Bone Marrow Transplantation (2021)
-
Spousal hematopoietic stem cell transplantation
International Journal of Hematology (2017)
-
Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient
Bone Marrow Transplantation (2006)